Recruiting
Phase 1
Phase 2

MNA with Doxorubicin

Sponsor:

Falo, Louis, MD

Code:

NCT05377905

Conditions

Cutaneous Squamous Cell Carcinoma

Skin Cancers - Squamous Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Microneedle Array Doxorubicin (MNA-D)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-07. This information was provided to ClinicalTrials.gov by Falo, Louis, MD on 2025-04-11.